A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines
Understanding the heterogeneous drug response of cancer patients is essential to precision oncology. Pioneering genomic analyses of individual cancer subtypes have begun to identify key determinants of resistance, including up-regulation of multi-drug resistance (MDR) genes and mutational alteration...
Main Authors: | Wang, Kendric, Shrestha, Raunak, Wyatt, Alexander W., Reddy, Anupama, Lehár, Joseph, Wang, Yuzhou, Lapuk, Anna, Collins, Colin C. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103868/ |
Similar Items
-
Optimally discriminative subnetwork markers predict response to chemotherapy
by: Dao, Phuong, et al.
Published: (2011) -
The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity
by: Barretina, Jordi, et al.
Published: (2012) -
The role of mRNA splicing in prostate cancer
by: Lapuk, Anna V, et al.
Published: (2014) -
Drug sensitivity in cancer cell lines is not tissue-specific
by: Jaeger, Samira, et al.
Published: (2015) -
PanSNPdb: The Pan-Asian SNP Genotyping Database
by: Ngamphiw, Chumpol, et al.
Published: (2011)